The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk of intracranial hemorrhage with direct oral anticoagulants versus low molecular weight heparin in glioblastoma: A retrospective cohort study.
 
Lauren Reed-Guy
No Relationships to Disclose
 
Arati Suvas Desai
No Relationships to Disclose
 
Richard Edmund Phillips
No Relationships to Disclose
 
Desiree Croteau
No Relationships to Disclose
 
Meghan O'Neill
No Relationships to Disclose
 
Karen Albright
No Relationships to Disclose
 
Steven Brem
No Relationships to Disclose
 
Donald M. O'Rourke
Consulting or Advisory Role - Celldex; Implicyte; Prescient Therapeutics
Research Funding - Celldex; Novartis; Tmunity Therapeutics, Inc.
Patents, Royalties, Other Intellectual Property - Novartis; Tmunity Therapeutics, Inc.; University of Pennsylvania
 
Nduka Amankulor
No Relationships to Disclose
 
Stephen Joseph Bagley
Consulting or Advisory Role - Bayer; Novocure; Sumitomo Dainippon Pharma Oncology
Research Funding - C2i genomics; GlaxoSmithKline; Guardant Health; Incyte; Lilly; Novocure; Tempus
Patents, Royalties, Other Intellectual Property - Co-inventor of intellectual property of the University of Pennsylvania licensed to Novartis: Combination Therapies of EGFRvIII Chimeric Antigen Receptors and PD-1 Inhibitors, US. Patent No. 62/809,245.
Travel, Accommodations, Expenses - Northwest Biotherapeutics